79 views
RXMD is a stock we liked a lot back at the start of July. And we still like it. The company continues to expand in its FL Covid testing range and it keeps putting up monster growth data.
The breakouts are coming in a stepwise trend. And the company has signaled a coming potential Nasdaq uplist.
The breakouts are coming in a stepwise trend. And the company has signaled a coming potential Nasdaq uplist.
Comments
Good luck.
I agree that the high-volume thrust got attention, and the Jun 26 breakout of the subsequent downtrend was a valid entry around .05
Recently the CHART is presenting clear issues: to keep it simple there's an obvious battle between .06 and .068. The struggle is real, ESPECIALLY in light of your 'fundamental' beliefs which suggest price 'should be' breaking out, rather than testing support. If that support breaks .055 is an obvious next-level, followed by .05- an historically heavily-traded level that suggests 'breakeven' for many.
Good luck w/ the position.